Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Spectral Medical Inc > Trading review from July 27 to today - Where is Paradigm? !!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(737)
•••
Comment by mercedesmanon Dec 22, 2021 7:05pm
130 Views
Post# 34256477

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Trading review from July 27 to today - Where is Paradigm? !!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Trading review from July 27 to today - Where is Paradigm? !!

"the anonymous selling is 99% institutional and high net worth selling through their brokerages. The people from the financing or people taking short positions. It didn't take a rocket scientist to see the company was talking smack and wasn't delivering on the promises."-BSW

ok so now it's changed from hedge funds to disillusioned small retailers, to 99% institutional high net worth individuals selling anonymously through those institutions. It's hard to keep up with your constantly morphing story ! 

And you're saying that those high net individuals ( smart money) were all convinced to sell because Seto flapped his gums and missed on his promises and targets. Do I have that right? I think that's your theory. But all the "dumb money" ( including you) decided to hold based on the underlying fundamentals, and despite Seto's gaffs. Some of the real idiots loaded up at .21 I guess  ?! 


I wish I made $200k so I could be smarter about these things. 

bwahahahaaahhaa !!

MM 


 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities